Head-to-head
Oak Longevity vs MEDVi
Compared on semaglutide across the eight dimensions this database records. They differ on 2 of those eight. Oak Longevity is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Oak Longevity is $133 a month all-in for semaglutide; MEDVi is $299. Over twelve months that is $1,596 against $3,588. Value Scores are 95.6 and 58.0 out of 100.
Semaglutide
Plan pages: Oak Longevity plans · MEDVi plans
At 2.4 mg/week, Oak Longevity is $133 a month all-in and MEDVi is $299 — $166 apart, or $1,992 across a year. Over twelve months the totals are $1,596 (billed monthly) and $3,588 (billed monthly).
Oak Longevity charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Oak Longevity | Rank | MEDVi | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $133 | 4/32 | $299 | 27/32 | Oak Longevity by $166 |
| 0.5 mg | $133 | 3/21 | $299 | 17/21 | Oak Longevity by $166 |
| 1 mg | $133 | 3/21 | $299 | 17/21 | Oak Longevity by $166 |
| 1.7 mg | $133 | 3/21 | $299 | 17/21 | Oak Longevity by $166 |
| 2.4 mg | $133 | 3/29 | $299 | 23/29 | Oak Longevity by $166 |
Oak Longevity is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Oak Longevity sits 2 of 29 on all-in monthly cost and MEDVi sits 25. There are 22 other programs priced between them. The field median is $249 and the floor is $129, so Oak Longevity is below the median and the other is above it. Oak Longevity is $4 above the cheapest semaglutide program on record. MEDVi is $170 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Oak Longevity undercuts it by $216, MEDVi by $50. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Oak Longevity | MEDVi | Cheaper |
|---|---|---|---|
| Month to month | $133 | $299 | Oak Longevity by $166 |
| Settled dose | Oak Longevity | MEDVi | Difference |
|---|---|---|---|
| 0.25 mg | $1,596 | $3,588 | $1,992 apart |
| 0.5 mg | $1,596 | $3,588 | $1,992 apart |
| 1 mg | $1,596 | $3,588 | $1,992 apart |
| 1.7 mg | $1,596 | $3,588 | $1,992 apart |
| 2.4 mg | $1,596 | $3,588 | $1,992 apart |
Oak Longevity publishes no rate for 3-month term, 6-month term, 12-month term; MEDVi publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,596 on Oak Longevity and $3,588 on MEDVi. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 95.6 for Oak Longevity and 58.0 for MEDVi, against a semaglutide category floor of $129. Oak Longevity leads by 37.6 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Oak Longevity | 67.9 | 12.8 | 10 | 5 | 95.6 |
| MEDVi | 30.2 | 12.8 | 10 | 5 | 58.0 |
Where the two programs differ
All-in monthly
Oak Longevity is cheaper month to month — $133 against $299, a gap of $166 every month, or $1,992 across a year if both rates hold.
Twelve-month cost
Over twelve months the totals are $1,596 for Oak Longevity and $3,588 for MEDVi. Oak Longevity is lower by $1,992 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Cancellation terms
Both state the same cancellation terms: Cancel before renewal.
Commitment
Commitment terms read the same on both: Month-to-month.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Oak Longevity Official site
A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly itemized), so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability confirmed at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — First-party pricing page capture 2026-08-08
Watch: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
MEDVi Official site
MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — medvi.com pricing capture 2026-08-05
Watch: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Which molecules each one carries
Oak Longevity carries semaglutide at $133 a month; does not offer tirzepatide.
MEDVi carries tirzepatide at $399 a month and semaglutide at $299 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Oak Longevity does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Availability confirmed at intake
MEDVi does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Ask Oak Longevity and MEDVi for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Oak Longevity Official site wins this matchup. On the structural dimensions the two are close enough that the choice comes down to availability in your state and which intake you prefer.
Both figures should be checked at the provider's own checkout before you pay. Oak Longevity's semaglutide price is provider-stated as of 2026-08-08; MEDVi's is provider-stated as of 2026-08-05.
Questions
Is Oak Longevity or MEDVi cheaper for semaglutide?
Oak Longevity is cheaper on all-in monthly cost at 2.4 mg/week: $133 against $299, a difference of $166 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Oak Longevity versus MEDVi?
Oak Longevity works out to $1,596 across twelve months and MEDVi to $3,588, on the plan terms each publishes.
Does Oak Longevity or MEDVi raise the price as the dose goes up?
Oak Longevity: no, it charges one flat rate at every dose. MEDVi: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Oak Longevity and MEDVi differ?
2 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Oak Longevity and MEDVi names its pharmacy?
Neither. Oak Longevity records Partner 503A pharmacy (not publicly itemized) and MEDVi records Partner pharmacies. Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Oak Longevity and MEDVi prices?
Oak Longevity's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. MEDVi's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Oak Longevity official site · MEDVi official site. Compounded tirzepatide and semaglutide are not FDA-approved products.